Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Transl Sci. 2018 Jul 13;5(2):10.15761/JTS.1000269. doi: 10.15761/JTS.1000269

Figure 3A.

Figure 3A.

False positive.

A 35-year-old female with NSCLC enrolled onto our study as HER2(−) based on pericardial effusion biopsy (HER2 2+; FISH ratio 1.22). The right upper lung lesion (the Target Lesion) is easily visualized (narrow arrows) on these fused SPECT/CT, SPECT, and low attenuation CT sagittal projections from the 71h post iv infusion of 128.4MBq[160.4ug] 111In-CHX-A”-DTPA trastuzumab imaging session. Tumor to Background Ratio is 6.7. The wider arrows show the liver.